Back to Journals » OncoTargets and Therapy » Volume 11

TIM-3, a promising target for cancer immunotherapy

Total article views   HTML views PDF downloads Totals
36,499 Dovepress* 15,020+ 2,176 17,196
PubMed Central* 21,479 2,940 24,419
Totals 36,499 5,116 41,615
*Since 16 October 2018
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 1 5

View citations on PubMed Central and Google Scholar